This population-based study compares the safety and long-term outcomes of multiple arterial grafting vs left internal thoracic artery supplemented by saphenous vein grafts among overall and selected subgroups of patients.
This analysis of data from the PARTNER Trial determines the midterm hemodynamic performance of balloon-expandable transcatheter heart valves.
This analysis of the PARTNER II trial examines the incidence, evolution, and effect on 1-year outcomes of paravalvular regurgitation following transcatheter aortic valve replacement with a third-generation balloon-expandable transcatheter heart valve.
This study evaluates patient access to PCSK9 inhibitors among those prescribed therapy.
This study describes temporal trends in bystander cardiopulmonary resuscitation and first-responder defibrillation for out-of-hospital cardiac arrests stratified by home vs public location and their association with survival and neurological outcomes.
This community-based cohort study of Framingham Heart Study participants applies unsupervised machine learning to define the distribution and prognostic importance of computed tomography–based multiorgan phenotypes associated with adverse health outcomes.
This cohort study determines whether mitochondrial DNA copy number, measured in an easy accessible tissue (buffy coat/circulating leukocytes), is associated with improved risk classification for cardiovascular disease and help guide initiation of statin therapy for primary prevention of cardiovascular disease.
This cohort study compares the clinical characteristics, presentation, and outcomes of peripartum cardiomyopathy between African American and non–African American women.
This study uses data from a large academic medical center to estimate the accuracy of the criteria used by Medicare to represent the burden of hospitalizations for heart failure.
This study uses linked data from Get With the Guidelines–Resuscitation and Medicare claims to assess the challenges of using administrative billing data to conduct research on 56678 patients with confirmed in-hospital cardiac arrest.
This analysis of postmarketing data related to a wireless pulmonary artery sensor finds approximately 2.8% of patients experience adverse events.
This Viewpoint discusses the benefit model vs risk-based prevention strategies for cardiovascular disease.
This Viewpoint discusses the implications of the Medicare Access and CHIP Reauthorization Act of 2015 on cardiologists.
This Viewpoint discusses how different measures of treatment effect for cardiovascular trials are interpreted for evidence-based communication and their caveats.
This article examines successful methods that have been used by researchers to engage patients, caregivers, and the broader health care community in the research process and offers examples of currently funded studies that have fully engaged key stakeholders.
A 34-year-old man with a history of ischemic cardiomyopathy that required a heart transplant presented to the hospital with shortness of breath. What would you do next?
Create a personal account or sign in to: